Economic benefits of the United States’ AIDS drug assistance Program: A systematic review of cost analyses to guide research and policy priorities

As part of the Ryan White HIV/AIDs Program, the federally-funded, state-administered AIDS Drug Assistance Program (ADAP) provides prescription drug medications, including antiretroviral therapy, for people with HIV (PWH) who are uninsured/underinsured and have a low income. ADAP expenditures are ∼$2...

Descripción completa

Detalles Bibliográficos
Autores principales: McManus, Kathleen A., Strumpf, Andrew, Killelea, Amy, Horn, Tim, Hamp, Auntré, Keim-Malpass, Jessica
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2022
Materias:
Short Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9502648/
https://www.ncbi.nlm.nih.gov/pubmed/36161113
http://dx.doi.org/10.1016/j.pmedr.2022.101969

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9502648/
https://www.ncbi.nlm.nih.gov/pubmed/36161113
http://dx.doi.org/10.1016/j.pmedr.2022.101969

Ejemplares similares